Department of Research, Cancer Registry of Norway, Oslo, Norway; Oslo and Akershus University College of Applied Sciences, Oslo, Norway.
Cancer. 2013 Sep 1;119(17):3106-12. doi: 10.1002/cncr.28174. Epub 2013 May 29.
The Norwegian Breast Cancer Screening Program started in 1996. To the authors' knowledge, this is the first report using individual-based data on invitation and participation to analyze breast cancer mortality among screened and nonscreened women in the program.
Information on dates of invitation, attendance, breast cancer diagnosis, emigration, death, and cause of death was linked by using unique 11-digit personal identification numbers assigned all inhabitants of Norway at birth or immigration. In total, 699,628 women ages 50 to 69 years without prior a diagnosis of breast cancer were invited to the program from 1996 to 2009 and were followed for breast cancer through 2009 and death through 2010. Incidence-based breast cancer mortality rate ratios (MRRs) were compared between the screened and nonscreened cohorts using a Poisson regression model. The MRRs were adjusted for calendar period, attained age, years since inclusion in the cohorts, and self-selection bias.
The crude breast cancer mortality rate was 20.7 per 100,000 women-years for the screened cohort compared with 39.7 per 100,000 women-years for the nonscreened cohort, resulting in an MRR of 0.52 (95% confidence interval, 0.47-0.59). The mortality reduction associated with attendance in the program was 43% (MRR, 0.57; 95% confidence interval, 0.51-0.64) after adjusting for calendar period, attained age, years after inclusion in the cohort, and self-selection bias.
After 15 years of follow-up, a 43% reduction in mortality was observed among women who attended the national mammographic screening program in Norway.
挪威乳腺癌筛查计划于 1996 年启动。据作者所知,这是首次使用基于个体的邀请和参与数据来分析该计划中筛查和未筛查女性的乳腺癌死亡率的报告。
通过使用唯一的 11 位数字个人识别号码将日期的邀请、出席、乳腺癌诊断、移民、死亡和死因信息联系起来,这些号码分配给了挪威所有出生或移民的居民。共有 699628 名年龄在 50 至 69 岁之间、无乳腺癌既往诊断的女性于 1996 年至 2009 年期间被邀请参加该计划,并通过 2009 年对乳腺癌进行随访,直至 2010 年死亡。使用泊松回归模型比较筛查和未筛查队列的基于发病率的乳腺癌死亡率比值(MRR)。MRR 调整了日历期、获得年龄、纳入队列后的年数以及自我选择偏差。
筛查队列的粗乳腺癌死亡率为 20.7/100000 女性年,而未筛查队列为 39.7/100000 女性年,MRR 为 0.52(95%置信区间,0.47-0.59)。在调整了日历期、获得年龄、纳入队列后的年数和自我选择偏差后,参加该计划与死亡率降低 43%相关(MRR,0.57;95%置信区间,0.51-0.64)。
在 15 年的随访后,挪威全国乳腺 X 线筛查计划中参加该计划的女性死亡率降低了 43%。